TPMT/NUDT15 genotyping (thiopurine toxicity panel)
- Children and young adults with acute lymphoblastic leukaemia about to be treated with mercaptopurine.
- Patients who have received a blood transfusion within the last 3 months as this may falsely raise TPMT enzyme activity.
- Patients on renal failure/renal transplant/dialysis. TPMT inhibitors may accumulate in the blood of patients in renal failure.
- Patients with very low Hb (Hb≤70g/L). Correlation between TPMT genotype and phenotype is poor for these patients.
Thiopurine toxicity panel:
Allele c.DNA Amino acid rs number
TPMT*2 c.238G>C p.(Ala80Pro) rs1800462
TPMT*3B c.460G>A p.(Ala154Thr) rs1800460
TPMT*3C c.719A>G p.(Tyr240Cys) rs1142345
NUDT15*3 c.415C>T p.(Arg139Cys) rs766023281
North Wing - 4th Floor
Westminster Bridge Road
London SE1 7EH
Last updated: 24/02/2023